Our products

For Grünenthal’s position on the responsible use of opioids, please follow this link.

Patients are at the heart of everything we do. Using our expertise and passion for science, we develop innovative solutions that directly address patients’ unmet needs.

Pain is one of the most common reasons why people seek medical help. Experts estimate that tens of millions of people experience moderate to severe pain with no access to adequate treatment. Chronic pain is a widespread health problem and although few people die of pain, many die in pain and even more live in pain.1,2

Pain has an enormous impact on quality of life: from low functionality to anxiety and depression, the comorbidities associated to chronic pain heavily impact the lives of patients with intractable pain and it’s only understandable that patients with chronic pain hold huge hopes for effective and innovative solutions.

  • To harness the power of science, we carry out integrated research and development to find innovative solutions for the treatment of pain whether such solutions are drugs or state-of-the-art technologies, our objective is to relieve pain.
  • Understanding the patients’ journey is key to our work as it contextualises our research and helps us understand where we need to create value along that journey from the first onset of symptoms to treatment initiation and beyond.

We are tirelessly developing life changing innovations that challenge the status quo.

Working hand-in-hand with patients, academics, healthcare professionals and policy makers, we are determined to develop unique solutions addressing diseases with high unmet needs. If we can have a significant and real impact on these people’s lives, then we have made their hopes a reality.

 

1 Treede RD, et al. Pain 2015 Jun;156(6):1003-1007.
2 Pain Alliance Europe, 2017, Survey on Chronic Pain 2017, Diagnosis, Treatment and Impact of Pain.

Portfolio of medicines Grünenthal Limited, UK

If you would like to know about Grünenthal’s list of Medicines in United Kingdom, please visit our company profile page on the electronic medicines compendium (emc).

The links below will direct you to www.medicines.org.uk/emc, an external website providing information about medicines in the UK, including the Patient Information Leaflet (PIL) and the Summary of Product Characteristics (SPC).

The product information provided in this site is intended for residents of the UK only. The following documents are hosted externally. Grünenthal UK Ltd. is not responsible for the content of external sites.

Grünenthal’s list of Medicines in the UK

For Medical Information, Reporting Safety and Quality Related Issues:

If you need more information about our products or wish to report an adverse event or product quality related issues, please contact our Medical Information department via email or telephone:

medicalinformationuk@grunenthal.com

 

Reporting of side effects/adverse events

Adverse events should be reported:
If, as a patient, you get any side effects talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side affects you can help provide more information on the safety of this medicine.

Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Grunenthal Ltd. at drugsafety.UK@grunenthal.com

M-N/A-UK-11-24-0001 - November 2024